Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)

NCT01420874 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Cancer of Pancreas
Pancreatic Neoplasm
Malignant Neoplasm of Large Intestine
Malignant Tumor of Colon
Colon Carcinoma
Cancer of Colon
Pancreatic Cancer

Interventions

DRUG: FOLFOX6
BIOLOGICAL: EGFRBi armed ATC Infusions

Sponsor

Barbara Ann Karmanos Cancer Institute